Shares in Stratagene rose 15.9 percent for the trading week ended Tuesday, a week after its shares had gained 17.4 percent. The firm had seen its shares slump to a 52-week low of $3.98 in the month leading up to the turnaround, but investors are clearly showing that they believe the stock was undervalued. The firm’s shares, however, have a long way to go before matching the 52-week high of $11.41.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.